as on January 13, 2026 at 2:29 am IST
Day's Low
Day's High
10.47%
Downside
0.52%
Upside
52 Week's Low
52 Week's High
29.32%
Downside
159.95%
Upside
Check Eledon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$129.8M
EPS (TTM)
-0.6325
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-36.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-95.49%
Compare market cap, revenue, PE, and other key metrics of Eledon Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $129.8M | -88.07% | NA | 0.00% | |
| BUY | $37.5B | 381.98% | -16.34 | -264.83% | |
| BUY | $52.6B | 140.44% | 1244.66 | 1.36% | |
| BUY | $118.9B | 102.22% | 32.69 | 31.35% | |
| BUY | $84.4B | 57.5% | 19.08 | 32.13% |
The Eledon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Eledon Pharmaceuticals Inc investment value today
Current value as on today
₹51,323
Returns
Returns from Eledon Pharmaceuticals Inc Stock
Dollar Returns*
₹4,046 (+4.05%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Eledon Pharmaceuticals Inc. Average target price of $8
Get share price movements and forecasts by analysts on Eledon Pharmaceuticals Inc.
What analysts predicted
76.13%UPSIDE
Target Price
$8
Current Price
$1.91
Analyzed by
12 Analysts
Target
$8.00
Eledon Pharmaceuticals Inc target price $8, a slight upside of 76.13% compared to current price of $1.91. According to 12 analysts rating.
Search interest for Eledon Pharmaceuticals Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 November
Fri, 07:20 PM
-Eledon Pharmaceuticals stock drops 52.2% after Phase 2 trial fails to meet primary endpoint for tegoprubart.
Sat, 00:06 AM
-Despite Phase 2 failure, Eledon plans to advance tegoprubart into Phase 3 development.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 169.7% return, outperforming this stock by 226.9%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 811.3% return, outperforming this stock by 850.9%
Price Dip
![]()
In the last 6 months, ELDN stock has moved down by -49.4%
| Organisation | Eledon Pharmaceuticals Inc |
| Headquarters | 19800 MacArthur Boulevard, Irvine, CA, United States, 92612 |
| CEO | Dr. David-Alexandre C. Gros M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. John Herberger | Vice President of Technical Operations |
Mr. Bryan E. Smith J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
Dr. David Hovland Ph.D. | Chief Regulatory Officer |
Dr. Eliezer Katz F.A.C.S., M.D. | Chief Medical Officer |
Ms. Marina Escudero | VP & Head of Clinical Operations |
Dr. David-Alexandre C. Gros M.D., Ph.D. | CEO & Non Independent Director |
Dr. Steven N. Perrin Ph.D. | President, Chief Scientific Officer & Non Independent Director |
Mr. Paul Sean Little | Chief Financial Officer |
Eledon Pharmaceuticals Inc share price today is $1.91 as on at the close of the market. Eledon Pharmaceuticals Inc share today touched a day high of $1.92 and a low of $1.71.
Eledon Pharmaceuticals Inc share touched a 52 week high of $4.97 on and a 52 week low of $1.35 on . Eledon Pharmaceuticals Inc stock price today i.e. is closed at $1.91,which is 61.53% down from its 52 week high and 41.48% up from its 52 week low.
Eledon Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Eledon Pharmaceuticals Inc (ELDN) shares with as little as ₹90.157 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.57 in Eledon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Eledon Pharmaceuticals Inc share’s latest price of $1.91 as on January 13, 2026 at 2:29 am IST, you will get 5.2356 shares of Eledon Pharmaceuticals Inc. Learn more about
fractional shares .
Eledon Pharmaceuticals Inc stock has given -88.07% share price returns and 23.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?